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Abstract
Nlrp1b is a NOD-like receptor that detects the catalytic activity of anthrax lethal toxin and subsequently co-oligomerizes into
a pro-caspase-1 activation platform known as an inflammasome. Nlrp1b has two domains that promote oligomerization: a
NACHT domain, which is a member of the AAA+ ATPase family, and a poorly characterized Function to Find Domain (FIIND).
Here we demonstrate that proteolytic processing within the FIIND generates N-terminal and C-terminal cleavage products
of Nlrp1b that remain associated in both the auto-inhibited state and in the activated state after cells have been treated
with lethal toxin. Functional significance of cleavage was suggested by the finding that mutations that block processing of
Nlrp1b also prevent the ability of Nlrp1b to activate pro-caspase-1. By using an uncleaved mutant of Nlrp1b, we established
the importance of cleavage by inserting a heterologous TEV protease site into the FIIND and demonstrating that TEV
protease processed this site and induced inflammasome activity. Proteolysis of Nlrp1b was shown to be required for the
assembly of a functional inflammasome: a mutation within the FIIND that abolished cleavage had no effect on self-
association of a FIIND-CARD fragment, but did reduce the recruitment of pro-caspase-1. Our work indicates that a post-
translational modification enables Nlrp1b to function.
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Introduction
Inflammasomes are multi-protein complexes that facilitate the
activation of pro-caspase-1 in response to pathogen associated
molecular patterns (PAMPS) or endogenous danger associated
molecular patterns (DAMPS). A common feature of inflamma-
somes is that they recruit multiple copies of pro-caspase-1, which
allows auto-proteolytic processing to generate active caspase-1 that
cleaves downstream targets including pro-IL-1b and pro-IL-18.
There are distinct mechanisms by which inflammasomes are
thought to cluster molecules of pro-caspase-1. AIM2 has a HIN
domain that binds cytosolic DNA derived from viruses or
intracellular bacterial pathogens; it is the binding of several
molecules of AIM2 to the same fragment of cytosolic DNA that
leads to the grouping of pro-caspase-1 via the ASC adaptor [1–3].
In contrast, NLRP3 and NLRC4 each have a NACHT domain
that self-associates to assemble a pro-caspase-1 activation platform
after their respective triggers release auto-inhibitory intra-molec-
ular interactions. Formation of the NLRP3 inflammasome has
been proposed to occur in response to lysosomal permeabilization
or reactive oxygen species generation [4–6], although recent
evidence suggests that reactive oxygen species may serve only to
induce the expression of NLRP3 [7]. The NLRC4 inflammasome
detects bacterial flagellin and secretion system components [8,9].
Human NLRP1 and the murine homolog, Nlrp1b, have NACHT
domains as well as a Function to Find Domain (FIIND) that
facilitate self-association [10,11]. Nlrp1b indirectly senses the
proteolytic activity of anthrax lethal toxin (LeTx) and there is some
evidence that NLRP1 may detect peptidoglycan [12–16].
LeTx is comprised of a protease, lethal factor (LF), and a second
component, protective antigen (PA), which binds mammalian cells
and translocates LF to the cytosol [17,18]. The proteolysis of
multiple members of the MAPKK family by LF results in
downregulation of the ERK, p38 and JNK signaling pathways.
Interference of these pathways explains many of the pathogenic
effects of LeTx, such as the inhibition of cytokine expression and
chemotaxis, but there is no clear link between inactivation of these
targets and activation of the Nlrp1b inflammasome [19].
Activation of Nlrp1b by LeTx causes macrophages to undergo a
form of caspase-1 dependent cell death known as pyroptosis [20].
Interestingly, induction of pyroptosis in macrophages promotes the
survival of mice infected with Bacillus anthracis by initiating IL-1b
signaling and neutrophil recruitment [21,22].
There are five alleles of Nlrp1b. Murine macrophages that
express either allele 1 or 5 are susceptible to LeTx-mediated
pyroptosis, but those that express allele 2, 3, or 4 are resistant [13].
The alleles are highly polymorphic: amino acid differences are
found within the NACHT domain, the leucine rich repeat (LRR)
domain, the FIIND, the caspase recruitment domain (CARD), as
well as inter-domain regions (Figure 1). Although there has been
little work done to examine the differences between the alleles, we
previously developed a reconstituted cell-based system and
confirmed that LeTx activated Nlrp1b allele 1 (Nlrp1b1,
AAZ40509.1), but not Nlrp1b allele 3 (Nlrp1b3, AAZ40520.1) –
there is a functional difference(s) between these proteins because
they were expressed at similar levels [11]. We also noted in
immunoblots that expression of Nlrp1b1 yielded two products,
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the protein, whereas Nlrp1b3 yielded only one product [11].
Recently, the human FIIND has been demonstrated to undergo
autoproteolysis [23]. D’Osualdo and colleagues detected sequence
similarity between the FIIND and the ZU5-UPA domain found in
the autoproteolytic protein PIDD, which is activated by DNA
damage. In both NLRP1 and PIDD, it is thought that a catalytic
serine attacks a strained segment of the polypeptide backbone to
generate two protein fragments that remain associated. Autopro-
teolysis of PIDD affects downstream signaling [24], but the
consequence of NLRP1 autoproteolysis is not known.
Here, we have studied the FIIND of Nlrp1b. We made a series
of truncation mutants to identify the minimal region of the FIIND
that can drive oligomerization of the CARD domain and
activation of pro-caspase-1. A multiple alanine substitution mutant
of this Nlrp1b1 fragment impaired self-association and pro-
caspase-1 activation. The same mutation abolished function of
full-length Nlrp1b1 and prevented cleavage within the FIIND, so
we hypothesized that cleavage of Nlrp1b is required for its
function. Comparison of the Nrlp1b1 and Nlrp1b3 sequences
allowed us to identify a single amino acid that determines the
difference in their susceptibilities to cleavage. We demonstrated
that cleavage is required for activity by introducing a heterologous
TEV protease site into a cleavage-deficient mutant of Nlrp1b1 and
showing that activation required co-expression of TEV protease.
Finally, we provide evidence that cleavage of Nlrp1b1 does not
facilitate its self-association, but does enhance the recruitment of
pro-caspase-1.
Results
Nlrp1b11100–1233 self-associates and activates pro-
caspase-1
Previous work demonstrated that Nlrp1b11086–1233 activates
pro-caspase-1 in the absence of LeTx [11]. To identify the smallest
constitutively active fragment of Nlrp1b1, we tested various
Nlrp1b1 truncation mutants for their potential to activate pro-
caspase-1 by reconstituting the Nlrp1b1 inflammasome in
HT1080 fibroblasts. Various Nlrp1b1 truncation mutants were
transfected into HT1080 cells along with pro-caspase-1 and pro-
IL-1b and then the supernatants were probed for HA-tagged IL-
1b by immunoblotting. In agreement with previous findings, IL-1b
was detected in supernatants of cells expressing Nlrp1b11086–1233,
which contains part of the FIIND plus the CARD domain, but not
the CARD domain alone, Nlrp1b11142–1233 (Figure 2A).
Nlrp1b11100–1233 induced IL-1b secretion, whereas Nlrp1b11102–
1233 exhibited little activity. These results indicate, therefore, that
Nlrp1b11100–1233 is the smallest fragment of Nlrp1b1 that can
optimally activate pro-caspase-1.
We next performed co-immunoprecipitation experiments to test
self-association of the Nlrp1b1 truncation mutants. HT1080 cells
were transfected with His6-Nlrp1b1-HA and His6-Nlrp1b1-T7
vectors containing the truncation mutants Nlrp1b11086–1233,
Nlrp1b11100–1233, Nlrp1b11102–1233 and Nlrp1b11142–1233. HA-
tagged proteins were immunoprecipitated and associated T7-
tagged proteins were detected by immunoblotting (Figure 2B).
Nlrp1b11086–1233 and Nlrp1b11100–1233 self-associated, but
Nlrp1b11102–1233 and Nlrp1b11142–1233 did not (Figure 2B). These
data support an induced-proximity model in which the self-
association of Nlrp1b1 is required to activate pro-caspase-1.
A multiple substitution mutation impairs Nlrp1b1
cleavage and activity
We next substituted residues 1100EIKLQIK1106 to alanine in
Nlrp1b11100–1233 and found that this mutant, Nlrp1b11100–1233-
7A, was impaired in its ability to self-associate and activate pro-
caspase-1 (Figure 3A, B). The mutation did not, however, affect
binding of catalytically inactive pro-caspase-1-C284A, which
demonstrates that Nlrp1b11100–1233-7A was not grossly misfolded
(Figure 3C). Notably, Nlrp1b11100–1233 and Nlrp1b11100–1233-7A
bound pro-caspase-1-C284A, whereas the CARD domain alone
(Nlrp1b11142-123) did not, indicating that a region N-terminal to
the CARD domain facilitates the recruitment of pro-caspase-1.
The multiple alanine substitution mutation was also introduced
Figure 1. Schematic domain structure of Nlrp1b. (A) Nlrp1b1
NACHT domain (residues 87–435), LRR domain (residues 627–719),
FIIND (residues 720–1141) and CARD domain (residues 1142–1233) are
shown. (B) Comparison of Nlrp1b alleles. Numbers refer to the amino
acid differences compared to allele 1 in each region of the protein.
Dashed lines indicate deleted sequences.
doi:10.1371/journal.ppat.1002659.g001
Author Summary
Inflammasomes are multi-protein complexes that respond
to signals derived from microbial pathogens or damaged
tissue. The function of an inflammasome is to activate pro-
caspase-1, a protease that contributes to the inflammatory
response by generating the cytokines IL-1b and IL-18. A
common feature of inflammasomes is their ability to
cluster multiple copies of pro-caspase-1 in a manner that
allows inter-molecular auto-proteolysis. The Nlrp1b inflam-
masome assembles in response to anthrax lethal toxin by
using two oligomerization regions: the NACHT domain and
the FIIND-CARD region. Here, we demonstrate that the
FIIND is proteolytically cleaved, but that the two fragments
of Nlrp1b generated from the cleavage remain associated
with one another. Cleavage within the FIIND is functionally
important, however, because mutants of Nlrp1b that are
not cleaved are not able to activate pro-caspase-1.
Furthermore, we were able to control cleavage by
inserting a heterologous protease site into Nlrp1b, which
allowed us to establish that processing of Nlrp1b is
required for its activity. Finally, we provide evidence that
processing of Nlrp1b facilitates the recruitment of pro-
caspase-1. Our work identifies a novel mechanism by
which the Nlrp1b inflammasome may be regulated.
Nlrp1b Is Proteolyically Processed
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caspase-1 in response to LeTx (Figure 3D). Interestingly, Nlrp1b1-
7A appeared as a single band in an immunoblot in contrast to the
two bands that are observed upon expression of wild-type Nlrp1b1
(Figure 3E). These results suggest a relationship between self-
association of the FIIND, cleavage of the FIIND, and activation of
pro-caspase-1.
Endogenous Nlrp1b1 is cleaved in murine macrophages
We sought to determine if endogenous Nlrp1b1 is proteolyti-
cally processed. First, we knocked down Nlrp1b1 in the murine
macrophage cell line J774A.1 and assayed for cell death in
response to LeTx. J774A.1 cells that were stably expressing
Nlrp1b1 shRNA showed considerable protection from LeTx-
induced cell death compared to cells expressing control shRNA,
indicating that the knockdown was functionally effective
(Figure 4A). We next probed these lysates with an antibody raised
against the N-terminus of Nlrp1b1. Although the Nlrp1b1
antibody detects several proteins non-specifically, comparing
lysates made from J774A.1 cells stably expressing either control
shRNA or Nlrp1b shRNA demonstrated that the knockdown of
Nlrp1b1 led to the disappearance of two bands (Figure 4B). These
bands had slightly lower molecular weights than the bands
corresponding to transfected TAP-tagged Nlrp1b1, which is
predicted to be 8 kDa larger than endogenous Nlrp1b1. That
the difference in molecular weight is similar between the two
endogenous bands and the two TAP-tagged bands suggests that
endogenous Nlrp1b1 is cleaved at the same location as transfected
Nlrp1b1.
Cleavage of Nlrp1b1 occurs in the FIIND
Because the TAP tag antibody and the Nlrp1b antibody both
detect epitopes at the N-terminus of Nlrp1b, the two bands
observed on the immunoblots likely correspond to full-length
Nlrp1b1 and the N-terminal fragment of cleaved Nlrp1b1. To
detect the C-terminal fragment, we generated an Nlrp1b1
construct with an additional TAP tag at the C-terminus. As
predicted, expression of this doubly tagged protein yielded three
bands: full-length Nlrp1b1, the N-terminal fragment, and the C-
terminal fragment (Figure 4C). Judging by the molecular weight of
the C-terminal fragment (estimated to be ,30 kDa without the
TAP tag), cleavage of Nlrp1b1 occurs in the FIIND.
Nlrp1b1-V988D is not cleaved and is not responsive to
LeTx
Based on the size of the C-terminal fragment and on the
observation that Nlrp1b1 is cleaved whereas Nlrp1b3 is not
cleaved, we speculated that an amino acid difference(s) between
Nlrp1b1 and Nlrp1b3 in the region near amino acids 970–1120
accounts for the lack of cleavage of Nlrp1b3. Six amino acid
differences were found near this region (Figure 5A), so we
generated 6 single swap mutants of Nlrp1b1. Of the 6 mutations,
only the V988D mutation resulted in a loss of cleavage of Nlrp1b1
(Figure 5B), suggesting that this difference between the two
proteins is responsible for the lack of cleavage of Nlrp1b3.
Notably, this mutation also resulted in a complete loss of
inflammasome activity in response to LeTx, as assessed by the
loss of mature IL-1b in the cell supernatant (Figure 5C). Several
other mutants (most markedly A996D and N1026S) resulted in
decreased inflammasome activity without affecting cleavage of
Nlrp1b1. These data suggest that the non-responsiveness of
Nlrp1b3 to LeTx is not only a consequence of it not being cleaved.
To determine if a single mutation could lead to the cleavage of
Nlrp1b3, a mutant containing the reverse of the V988D mutation,
Nlrp1b3-D927V, was made (the difference is numbering is due to
an insertion in Nrlp1b1). Nlrp1b3-D927V was cleaved, but it was
not able to activate pro-caspase-1 in response to LeTx (Figure 5D,
E). In an attempt to generate a functional version of Nlrp1b3, we
introduced swap mutations based on the mutations that impaired
function of Nrlp1b1 (A996D and N1026S). Nlrpb3-D935A/
S965N did not exhibit any activity, but Nlrp1b3-D927V/
D935A/S965N was cleaved and displayed activity (Figure 5F,
G). This triple mutant was constitutively active, presumably
because the mutations also interfere with auto-inhibition of the
protein.
Cleavage of Nlrp1b1 affects its activity
We next sought to determine whether proteolytic processing of
Nlrp1b1 is important for its activity by introducing a heterologous
protease site whose cleavage could be controlled. A cleavage site
for the tobacco etch virus (TEV) NIa protease was inserted
between amino acids 981 and 982 of Nlrp1b1-V988D. Impor-
tantly, TEV protease has high sequence specificity and is well
tolerated by mammalian cells [25]. Nlrp1b1, Nlrp1b1-V988D,
and Nlrp1b1-V988D-TEV were each co-expressed with pro-
Figure 2. Nlrp1b11100–1233 self-associates and actives pro-
caspase-1. (A) HT1080 cells were co-transfected with Nlrp1b1
truncation constructs, pcDNA3-pro-caspase-1-FLAG and pcDNA3-pro-
IL-1b-HA as indicated. After 24 h, cells were lysed and lysates were
probed for T7-tagged Nlrp1b truncation mutants and b-actin by
immunoblotting; supernatants were immunoprecipitated with anti-HA
antibodies and then probed for HA-tagged IL-1b. (B) HT1080 cells were
transfected with pcDNA3-His6-Nlrp1b1-HA and pcDNA3-His6-Nlrp1b1-
T7 tagged Nlrp1b1 truncation constructs as indicated. Cells were lysed
24 h after transfection, and proteins were immunoprecipitated using
anti-HA antibody, followed by immunoblotting with anti-T7 antibody
and anti-HA antibody. Blots are representative of three independent
experiments.
doi:10.1371/journal.ppat.1002659.g002
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IL-1b by cells that expressed Nlrp1b1 regardless of whether TEV
protease was expressed (Figure 6A). TEV protease did not cause
the release of IL-1b in the absence of LeTx. Nlrp1b1-V988D was
not functional in any of the conditions tested, whereas Nlrp1b1-
V988D-TEV activated pro-caspase-1, but only in the presence of
TEV protease. That TEV protease was able to promote pro-
caspase-1 activation by Nlrp1b1-V988D-TEV in the absence of
LeTx indicated that TEV cleavage overrides auto-inhibition of
Nlrp1b1.
Cleavage of Nlrp1b1-V988D-TEV was not observed under
conditions similar to those used to test activity (with the exception
that the catalytically inactive mutant pro-caspase-1-C284A was
used in order to prevent release of inflammasome components
from the cell), indicating that only a small fraction of Nlrp1b1-
V988D-TEV may have been cleaved (Figure 6B). To confirm that
Figure 3. Mutation of amino acids 1100–1106 impairs FIIND self-association, FIIND cleavage, and Nlrp1b1 activity. (A) Nlrp1b11100–
1233 or Nlrp1b11100–1233-7A (containing alanine substitution mutations of amino acids 1100–1106) was expressed with pro-caspase-1 and pro-IL-1b-
HA in HT1080 cells. Cells were lysed 24 h after transfection. Cell lysates were probed for T7-tagged Nlrp1b1 constructs and for b-actin by
immunoblotting; supernatants were immunoprecipitated with anti-HA antibodies and then probed for HA-tagged IL-1b. (B) T7-tagged and HA-
tagged Nlrp1b11100–1233 or Nlrp1b11100–1233-7A were expressed in HT1080 cells. HA-tagged proteins were immunoprecipitated from cell lysates and
the immunprecipitates were probed for T7- and HA-tagged proteins. (C) HA-tagged Nlrp1b11100–1233, Nlrp1b11100–1233-7A and Nlrp1b11142–1233 were
co-expressed with pro-caspase-1-C284A-T7. Immunoprecipitations were performed with anti-T7 or control anti-GFP antibodies and immunoblotted
for HA and T7 epitopes. Cell lysates (right panel) were immunoblotted as indicated. (D) Nrlp1b1 and Nrlp1b1-7A were expressed with pro-caspase-1
and pro-IL-1b-HA in HT1080 cells. Cells were treated with LeTx for 3 h and supernatants were probed for IL-1b-HA as above. (E) Cell lysates from (D)
were probed for Nlrp1b1. Blots are representative of three independent experiments.
doi:10.1371/journal.ppat.1002659.g003
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responsible for the observed activity, rather than an indirect effect
of the protease, a TEV-site mutant was generated. Nlrp1b1-
V988D-TEVmut has a Q to H mutation in the consensus
sequence ENLYFQS, which has been shown to prevent cleavage
by TEV protease [26]. Because cleavage by TEV protease could
not be visualized under the conditions used to test inflammasome
activation (Figure 6B), 5 times as much plasmid encoding TEV
protease was transfected with the Nlrp1b1 constructs. Under these
conditions, a small amount of cleaved product of Nlrp1b1-V988D-
TEV was observed, whereas no cleavage of Nlrp1b1-V988D-
TEVmut was detected (Figure 6C). Nlrp1b1-V988D-TEV exhib-
ited activity when co-expressed with TEV protease, but Nlrp1b1-
V988D-TEVmut did not (Figure 6D). Cumulatively, these results
provide strong evidence that cleavage of Nlrp1b1 is important for
its function.
Cleaved fragments of Nlrp1b1 remain associated
We next wanted to determine whether the N-terminal and C-
terminal fragments of Nlrp1b1 are associated in the auto-inhibited
state and if activation of Nlrp1b1 by LeTx causes the C-terminal
fragment to be released as an activated moiety. Nlrp1b1 was
expressed with an N-terminal TAP tag and a C-terminal HA tag.
When Nlrp1b1 was precipitated using the TAP tag, the C-terminal
fragment co-precipitated (Figure 7). Treatment of cells with LeTx
for 1–2 h did not reduce the amount of C-terminal fragment
precipitated. Treatment of cells with LeTx for 3 h slightly reduced
the amount of the C-terminal fragment precipitated, although this
was because less was present in the lysate possibly as a result of
inflammasome secretion. Thus, LeTx does not cause cleaved
Nlrp1b1 to dissociate.
The V988D mutation reduces the ability of Nlrp1b1720–
1233 to associate with pro-caspase-1
We next sought to determine how cleavage within the FIIND
promotes inflammasome assembly. To ascertain whether process-
ing within the FIIND facilitates the ability of the FIIND-CARD
fragment to self-associate or to recruit pro-caspase-1, we used the
constructs Nlrp1b1720–1233 and Nlrp1b1720–1233-V988D, which
contain the entire FIIND-CARD region. Nlrp1b1720–1233 dis-
played constitutive activity as we have shown previously [11], but
the V988D mutant had minimal activity (Figure 8A). An
experiment was then performed in which T7-tagged Nlrp1b1
constructs were immunoprecipitated and the co-precipitation of
HA-tagged Nlrp1b1 constructs and FLAG-tagged pro-caspase-1-
C284A was tested. Nlrp1b1720–1233 self-associated in the presence
or absence of pro-caspase-1-C284A (Figure 8B). Nlrp1b1720–1233
also complexed with pro-caspase-1-C284A. Nlrp1b1720–1233-
V988D exhibited a slightly higher level of self-association
compared to the wild-type construct, but bound less pro-
caspase-1-C284A. These experiments suggest that cleavage within
the FIIND facilitates the formation of an optimally assembled
platform that can recruit pro-caspase-1.
Discussion
NLRP1 and Nlrp1b appear to be unique among the NOD-like
receptors in that they possess two regions that facilitate
oligomerization: a NACHT domain and a FIIND-CARD region.
The NACHT domain is a member of the well-characterized
AAA+ ATPase family [27], while there is only limited information
available on the FIIND. In this study, we discovered that cleavage
of the Nlrp1b FIIND is functionally important for inflammasome
activity and that this processing of the FIIND facilitates the
recruitment of pro-caspase-1.
Previously, we noted that immunblotting for Nlrp1b1 using an
antibody against the N-terminal TAP tag detected two bands [11].
We speculated that the upper band represented the full-length
Figure 4. Nlrp1b1 is cleaved within the FIIND. (A) Untransduced
J774A.1 cells, or J774A.1 cells stably expressing scrambled shRNA or
Nlrp1b shRNA were treated with LeTx (10
29 M LF and 10
28 M PA) for
4 h and cell supernatants were assayed for LDH activity as an indication
of cell death. Error bars indicate SEM of three independent experiments.
(B) HT1080 cells were either transfected with pNTAP empty vector or
pNTAP-Nlrp1b1. Approximately 24 h after transfection, cells were lysed
and TAP-tagged proteins were precipitated with streptavidin resin.
Precipitated TAP-tagged proteins and lysates from J774A.1 cells stably
expressing either scrambled shRNA or Nlrp1b shRNA were subjected to
immunoblotting using an anti-Nlrp1b1 antibody. Arrows indicate two
bands present in control, but not in Nlrp1b1 knockdown lysates. (C)
HT1080 cells were transfected with either pNTAP empty vector, pNTAP-
Nlrp1b1, or pNTAP-Nlrp1b1-TAP. Approximately 24 h following trans-
fection, cells were lysed and TAP-tagged proteins were precipitated
with streptavidin resin and immunoblotted using an antibody directed
against the TAP tag. Arrows indicate full-length Nlrp1b1 and two
cleaved fragments of Nlrp1b1.
doi:10.1371/journal.ppat.1002659.g004
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By generating a construct with tags at both termini of Nlrp1b1, we
were able to detect the C-terminal fragment and determine that it
remained associated with the N-terminal fragment (Figure 7). That
the processing of Nlrp1b1 might be important for function was
hinted at by the finding that the LeTx-non-responsive Nrlp1b3
was not cleaved. Furthermore, a substitution mutation that we
designed to impair self-association of the FIIND unexpectedly
prevented Nlrp1b1 cleavage. The functional importance of FIIND
cleavage was established by an experiment in which the TEV
Figure 5. The V988D mutation in Nlrp1b1 eliminates both cleavage and inflammasome activity. (A) Alignment of allele 1 with allele 3
from amino acid 969 to 1112 of Nlrp1b1. Highlighted amino acid differences use numbering from allele 1. (B, D, and F) HT1080 cells were transfected
with pNTAP plasmids encoding the indicated Nlrp1b proteins. Approximately 24 h following transfection, cells were lysed and TAP-tagged proteins
were precipitated with streptavidin resin and immunoblotted using an Nlrp1b antibody. (C, E, and G) Cells were transfected with pNTAP plasmids
encoding the indicated Nlrp1b constructs, as well as with pcDNA3-pro-caspase-1-T7 and pcDNA3-pro-IL-1b-HA. Approximately 24 h after
transfection, cells were treated with LeTx (10
28 M LF and 10
28 M PA) for 3 h. Cell lysates were collected and probed for HA-tagged pro-IL-1b and b-
actin; cell supernatants were collected and immunoprecipitated with anti-HA antibodies and probed for HA-tagged IL-1b by immunoblotting. Blots
are representative of three independent experiments.
doi:10.1371/journal.ppat.1002659.g005
Nlrp1b Is Proteolyically Processed
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estimated to be near the natural cleavage site – TEV protease
cleaved this site and activated the inflammasome.
During the preparation of this manuscript, D’Osualdo and
colleagues published that the FIINDs of human NLRP1 and
CARD8 undergo autoproteolytic processing [23]. These research-
ers used computational approaches to detect similarity between
the FIIND and the ZU5-UPA domains found in the PIDD
autoprotease. PIDD forms a complex called the PIDDosome that
either activates pro-casapase-2 or NF-kb in response to DNA
damage. PIDD that is autoproteolytically cleaved at a single site
initiates activation of NF-kb; an additional autoproteolytic event
facilitates activation of pro-caspase-2 [24]. Autoproteolysis at each
site occurs before a serine residue – the hydroxyl group of the
serine is believed to attack a strained backbone to initiate the
breakage of the peptide bond.
Figure 6. Restoration of cleavage in the Nlrp1b1 V988D mutant rescues inflammasome activity. (A and D) Cells were transfected with
pcDNA3-pro-IL-1b-HA and pcDNA3-pro-caspase-1-T7 in addition to the indicated combinations of pNTAP plasmids encoding Nlrp1b proteins and
pcDNA3-TEV-protease-T7. Approximately 24 h after transfection, cells were treated with LeTx for 3 h. Cell lysates were collected and probed for HA-
tagged pro-IL-1b and b-actin; cell medium was collected and immunoprecipitated with anti-HA antibodies and probed for HA-tagged IL-1b by
immunoblotting. (B) HT1080 cells were transfected with pNTAP plasmids encoding Nlrp1b proteins, pcDNA3-pro-IL-1b-HA, and pcDNA3-TEV-
protease-T7 as indicated. Approximately 24 h after transfection, cells were treated with LeTx (10
28 M LF and 10
28 M PA) for 3 h. Cells were lysed and
TAP-tagged proteins were precipitated with streptavidin resin and immunoblotted using an Nlrp1b antibody. (C) Cells were transfected with pNTAP
plasmids encoding the indicated Nlrp1b proteins and pcDNA3-TEV-protease-T7 as indicated. Approximately 24 h following transfection, cells were
lysed and TAP-tagged proteins were precipitated with streptavidin resin and immunoblotted using an Nlrp1b antibody. Arrow indicates cleavage
product. Blots are representative of three independent experiments.
doi:10.1371/journal.ppat.1002659.g006
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after a phenylalanine residue in a conserved SFS motif [23], which
corresponds to 982SFS984 in Nlrp1b1. Notably, we found that the
nearby V988D mutation in Nlrp1b1 abolished cleavage and the
corresponding swap mutation in Nlrp1b3 caused this protein to be
cleaved. Furthermore, the TEV site that allowed activation of
Figure 7. The cleaved products of Nlrp1b1 remain associated. (A) HT1080 cells were transfected with the indicated Nlrp1b1 plasmids.
Approximately 24 h following transfection, cells were treated with LeTx (10
28 M LF and 10
28 M PA) for the indicated times. Cells were lysed and TAP-
tagged proteins were precipitated with streptavidin resin. Proteins from the precipitates and the lysates were immunoblotted with antibodies against
HA and b-actin. Blots represent three independent experiments.
doi:10.1371/journal.ppat.1002659.g007
Figure 8. The V988D mutation in Nlrp1b1720–1233 reduces its ability to associate with pro-caspase-1. (A) HT1080 cells were transfected
with pcDNA3-pro-caspase-1-T7 and pcDNA3-pro-IL-1b-HA and co-transfected as indicated with pNTAP-Nlrp1b1720–1233-HA, pNTAP-Nlrp1b1720–1233-
T7, pNTAP-Nlrp1b1720–1233-V988D-HA, and pNTAP-Nlrp1b1720–1233-V988D. Approximately 24 h after transfection, cell lysates were collected and
probed for HA-tagged pro-IL-1b and b-actin; cell supernatants were collected and immunoprecipitated with anti-HA antibodies and probed for HA-
tagged IL-1b by immunoblotting. (B) Cells were transfected with indicated combinations of pNTAP-Nlrp1b1720–1233-HA and pNTAP-Nlrp1b1720–1233-T7
WT or V988D as well as with pcDNA3-pro-caspase-1-C284A-FLAG and pcDNA3-pro-IL-1b-HA. Approximately 24 h following transfection, cells were
lysed and immunoprecipitated using an anti-T7 antibody. Proteins were immunoblotted with antibodies against HA, caspase-1, T7 and b-actin. Blots
are representative of three independent experiments.
doi:10.1371/journal.ppat.1002659.g008
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amino acids 981 and 982. Collectively, these findings suggest that
the V988D mutation disrupts the protein conformation required
for autoproteolysis between amino acids 983 and 984, but that
activity can be rescued by cleavage at a nearby location. We
believe that Nlrp1b1 undergoes autoproteolysis by the same
mechanism as CARD8 because Nlrp1b1-S984A, in which the
predicted catalytic serine is mutated, is not cleaved and is not
functionally active (Figure S1). We further note that although
lethal factor is itself a protease, the toxin does not affect Nlrp1b1
cleavage and, therefore, we do not believe that Nlrp1b1 is a direct
target.
Only approximately half of overexpressed Nlrp1b1 and
endogenous Nlrp1b1 is cleaved. We did not observe an increased
amount of cleavage over time (data not shown), which suggests
that only a fraction of Nlrp1b1 is capable of undergoing
autoproteolysis. We speculate, therefore, that auto-inhibited
Nlrp1b1 exists as a dimer in which one of the monomers is
cleaved and the other is not cleaved. Dimerization might induce
autoproteolysis in one of the monomers and not in the other,
which could explain why mutation of amino acids 1100–1106 not
only prevents self-association of Nlrp1b11100–1233, but also
prevents cleavage of Nlrp1b1.
To address the mechanistic consequence of FIIND processing,
we compared Nlrp1b1720–1233 to Nlrp1b1720–1233-V988D, which
contain the complete FIIND and CARD domains. Nlrp1b1720–
1233 is cleaved and is constitutively active; the V988D mutation
abolishes both cleavage and activity. We found that the V988D
mutation does not impair self-association – and in fact seems to
increase self-association to a small extent – but the mutation does
impair the recruitment of pro-caspase-1. We interpret these data
to mean that cleavage of the FIIND is required for the proper
assembly of a platform that is capable of recruiting molecules of
pro-caspase-1 in orientations that allow cross-proteolysis. Incorrect
assembly of uncleaved FIIND-CARD may partially occlude the
pro-caspase-1 binding site because self-association of FIIND-
CARD does not appear to be required for binding pro-caspase-1,
as demonstrated by binding of pro-caspase-1 to oligomerization-
defective Nlrp1b11100–1233-7A. Because Nlrp1b11100–1233 is active
even though it lacks the region that undergoes proteolysis, it is
presumably the uncleaved region N-terminal to amino acids
1100–1233 that exerts a negative restraint that prevents correct
assembly.
Materials and Methods
Cell lines and toxin
HT1080 cells and J774A.1 cells (ATCC) were cultured in
Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum and 1% penicillin-streptomycin. PA and LF
were purified as described previously [28].
Antibodies
Rabbit antibody was raised against an N-terminal epitope of
Nlrp1b1, MEESPPKQKSNTKVAQHE. Membranes were
probed with the following antibodies: anti-Nlrp1b polyclonal
antibody (1:5000), anti-caspase-1 p10 (M20) polyclonal antibody
(1:500, Santa Cruz Biotechnology sc-514), anti-HA polyclonal
antibody (1:1000, Santa Cruz Biotechnology sc-805), anti-T7-tag
monoclonal antibody (1:1000, Novagen 69522), anti-b-actin
monoclonal antibody (1:10000, Sigma Aldrich A-5441), and
anti-calmodulin binding peptide (CBP) antibody (1:1000, Upstate
07-482). For immunoprecipitations, anti-T7-tag monoclonal
antibody (Novagen 69522), and anti-HA monoclonal antibody
(Sigma H9658) were used. Anti-green fluorescent protein (GFP,
Covance MMS-118R) was used as a control.
Plasmid construction and site-directed mutagenesis
Construction of plasmids pcDNA3-T7, pcDNA3-His6-HA,
pcDNA3-His6-T7, pN-TAPA Nlrp1b1, pcDNA3-pro-caspase-1-
T7, pcDNA3-IL-1b-HA were described previously [11]. All
substitution mutations were made using Quikchange mutagenesis
(Stratagene).
To construct pcDNA3-pro-caspase-1-FLAG, pcDNA3-pro-cas-
pase-1-T7 was cut with Apa1 and Nhe1 to remove the T7 tag.
FLAG-tag oligonucleotide was constructed by annealing forward
oligonucleotide 59-CAT GGA CTA CAA GGA CGA CGA TGA
CAA GG-39 and reverse oligonucleotide 59-CTA GCC TTG
TCA TCG TCG TCC TTG TAG TCC ATG GGC C-39. The
resulting annealed oligonucleotide was ligated at Apa1 and NheI
restriction sites of the restriction digested pcDNA3-pro-caspase-1-
T7 vector.
pN-TAPB-T7 plasmid was constructed by annealing T7-tag
forward oligonucleotide 59- TCG AGA TGG CTA GCA TGA
CTG GTG GAC AGC AAA TGG GTT AGG GGC C-39 and
reverse oligonucleotide 59-CCT AAC CCA TTT GCT GTC
CAC CAG TCA TGC TAG CCA TC-39. The resulting annealed
T7 oligonucleotide was ligated at Xho1 and Apa1 restriction sites
of pN-TAPB.
Nlrp1b truncation plasmids were constructed by amplifying
fragments from pN-TAPA -Nlrp1b1. The PCR products were
digested with the restriction enzymes BamHI and XhoI, and the
resulting products were ligated into vectors pN-TAPB-T7,
pcDNA3-His6-HA and pcDNA3-His6-T7.
pC-TAPA-Nlrp1b1 was constructed by amplifying Nlrp1b1
with the forward primer 59-GCG GGA TCC GCC GCC ACC
ATG GAA GAA TCC CCA CCC AAG-39 and the reverse
primer 59-GCG CTC GAG TGA TCC CAA AGA GAC CCC
AC-39. The PCR product was digested with BamHI and XhoI
and ligated into pC-TAPA.
pN-TAPA-Nlrp1b1-TAP was constructed by amplifying the C-
terminus of Nlrp1b1 and the TAP tag from the pC-TAPA-
Nlrp1b1 plasmid using the forward primer 59-CGC ACC CAA
GCT TCT CCC CAA TGG-39 and the reverse primer 59-CGC
CTC GAG CTA AAG TGC CCC GGA GGA TG-39. The PCR
product and pN-TAPA-Nlrp1b1 were digested with HindIII and
XhoI. The vector backbone of pN-TAPA including the N-
terminus of Nlrp1b1 were isolated by gel extraction (Qiagen) and
ligated with the PCR product.
The NIa protease of the tobacco etch virus (TEV protease) was
amplified using the forward primer 59-CGC GGT ACC GCC
GCC ACC ATG GGA TCC AGC TTG TTT AAG GGA C-39
and the reverse primer 59-CGC TCT AGA GTC ACG ATG
AAT TCC GGG CGA G-39. The PCR product was digested with
KpnI and XbaI and ligated into pcDNA3-T7. In order to reduce
the self-cleavage and increase the catalytic efficiency of TEV
protease a S219V mutation [29] was introduced using the forward
primer 59-GGG GCC ATA AAG TTT TCA TGG TCA AAC
CTG AAG AGC CTT TTC-39 and the reverse primer 59-GAA
AAG GCT CTT CAG GTT TGA CCA TGA AAA CTT TAT
GGC CCC-39.
The pN-TAPA-Nlrp1b1-V988D-TEV construct was cloned in
two steps. The N-terminus of Nlrp1b1 was amplified with the
forward primer 59-CGC GGA TCC TAT GGA AGA ATC CCC
ACC CAA G-39 and the reverse primer (which includes coding for
the TEV-site) 59-CGC ATC GTC GAC TGG AAG TAG AGA
TTC TCT GGG TTT TTC AGT ACT GTG TAT CC-39. The
C-terminus of Nlrp1b1 was amplified from pNTAP-Nlrp1b1-
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CTT CTC CCC AAT GGG AGA TG-39 and the reverse primer
59-CGC CTC GAG TCA TGA TCC CAA AGA GAC CCC
ACC TG-39. The PCR fragments were digested with SalI and
ligated. After gel extraction, the ligated PCR fragments were
digested with BamHI and XhoI and ligated into pN-TAPA.
To construct pcDNA3-His6-Nlrp1b1-HA, Nlrp1b1 was ampli-
fied using the forward primer 59-CGC GGA TCC ATG GAA
GAA TCC CCA CCC AAG-39 and the reverse primer 59- CGC
CTC GAG TGA TCC CAA AGA GAC CCC AC-39. The PCR
product was digested using BamHI and XhoI followed by ligation
into pcDNA3-His6-HA.
The pN-TAPA-Nlrp1b1-HA construct was created by amplify-
ing Nlrp1b1 including the C-terminal HA tag from pcDNA3-
His6-Nlrp1b-HA. The forward primer used was 59-CGC GGA
TCC TAT GGA AGA ATC CCC ACC CAA G-39 and the
reverse primer was 59-CGC ATC GTG GTC GAC TCA CAA
GCT AGC GTA ATC TGG-39. The PCR product was digested
with BamHI and SalI and ligated into pN-TAPA.
pN-TAPB-Nlrp1b1720–1233-T7 was constructed by amplifying
Nlrp1b1 using the forward primer 59-GCG GGA TCC GAC
CTG TCC TCT CTC AGT G-39 and the reverse primer 59-
CGC CTC GAG TGA TCC CAA AGA GAC CCC AC-39. The
PCR product was digested with BamHI and XhoI and ligated into
pN-TAPB-T7.
The pN-TAPB-Nlrp1b1720–1233-HA construct was created by
amplifying the FIIND and CARD domains of Nlrp1b1 including
the C-terminal HA tag from pcDNA3- His6-Nlrp1b-HA. The
forward primer used was 59-GCG GGA TCC GAC CTG TCC
TCT CTC AGT GCC-39 and the reverse primer was 59-CGC
ATC GTG GTC GAC TCA CAA GCT AGC GTA ATC TGG-
39. The PCR product was digested with BamHI and SalI and
ligated into pN-TAPB.
Nlrp1b1 knockdown with shRNA
Design and infection of shRNA were performed according to
pLKO.1 protocol from Addgene. Nlrp1b1 shRNA was targeted
against the 39 UTR of Nlrp1b1. The Nlrp1b1 shRNA forward
sequence was 59-CCG GGG TTG TCT TTG TCT CTG TTG
ACT CGA GTC AAC AGA GAC AAA GAC AAC C-39 and the
reverse sequence was 59-AAT TCA AAA AGG TTG TCT TTG
TCT CTG TTG ACT CGA GTC AAC AGA GAC AAA GAC
AAC C-39. The scrambled shRNA sequences were generated from
the Nlrp1b1 shRNA sequence and the forward sequence was 59-
CCG GGG TCT TGT ATT CGG TTT CTG TCT CGA GAC
AGA AAC CGA ATA CAA GAC CTT TTT G-39 while the
reverse sequence was 59-AAT TCA AAA AGG TCT TGT ATT
CGG TTT CTG TCT CGA GAC AGA AAC CGA ATA CAA
GAC C-39. Forward and reverse oligonucleotides were annealed
and ligated into the pLKO.1 vector at the EcoRI and AgeI sites.
pLKO.1 vector containing the shRNA was transfected with
polyethylenimine, pH 7.2 into HEK-293T cells (ATCC). Approx-
imately 48 h following transfection, cell medium was collected and
filtered with a 0.45 mm filter and 2 mL of the lentiviral particle
solution was added to a 10 cm dish containing J774A.1 cells.
Approximately 24 h later, media was removed and media
containing 5 mg/ml puromycin (Sigma) was added to J774A.1
cells to select cells that had stably integrated the shRNA expressing
plasmid.
Lactate dehydrogenase release assay
J774A.1 cells were seeded onto a 24-well plate at 1.4610
5 cells
per well. Approximately 24 h later cells were treated with LeTx
(10
28 M PA and 10
29 M LF) for 4 h. Release of cytoplasmic
LDH into the cell medium was measured using the CytoTox 96
nonradioactive cytotoxicity assay (Promega G-1780) in accordance
with the manufacturer’s instructions. The percent of LDH release
was calculated as 1006(Experimental LDH2Spontaneous LDH)/
(Maximum LDH2Spontaneous LDH). J774A.1 WT 2LeTx and
+LeTx values were set to 0% and 100% respectively, and
scrambled and Nlrp1b shRNA J774A.1 results were normalized to
those values. Results from three independent experiments were
averaged.
IL-1b release assay
Approximately one million HT1080 cells were seeded on a 10-
cm dish the day before transfection. On the day of transfection,
1 mg each of pN-TAP-Nlrp1b1, pcDNA3-pro-caspase-1-FLAG (or
T7), and pcDNA3-pro-IL-1b-HA was transfected using 9 mlo f
1 mg/ml polyethylenimine, pH 7.2. Note that for experiments
involving TEV protease an additional 1 mg of either pcDNA3-
TEV-protease-T7 or pcDNA3 empty vector was transfected as
indicated. Approximately 24 h after transfection, cells were treated
with LF (10
28 M) and PA (10
28 M) for 3 h. The cell supernatant
was mixed with 1 ml of anti- HA antibody (Sigma-Aldrich H9658)
overnight, followed by the addition of 100 ml of BSA-blocked
protein A Sepharose beads (GE Healthcare) and a 2 h incubation.
Proteins were eluted from the protein A Sepharose beads with
sodium dodecyl sulfate (SDS) loading dye and subjected to
immunoblotting using a polyclonal HA antibody (Santa Cruz
sc805). Cells from each 10-cm plate were scraped into 300 mlo f
EBC lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 0.5% [vol/
vol] NP-40, 1 mM phenylmethylsulfonyl fluoride). Each sample
was lysed by rotation at 4uC for 1 h or by sonication 3 times, each
for 10 s followed by a 10 s incubation on ice. Lysates were clarified
by centrifugation, and protein concentrations were determined
using the Bradford assay. Equivalent amounts of cell lysate protein
(,40 mg) were subjected to SDS-polyacrylamide gel electropho-
resis and immunoblotted with anti-HA, anti-T7, and anti-b-actin
antibodies.
Detection of TAP-tagged proteins
One to five 10-cm dishes of HT1080 cells were transfected with
1–4 mg of the indicated constructs. Approximately 24 h after
transfection, cells were harvested and cell pellets from each plate
were lysed with approximately 300 ml EBC buffer by sonication.
Cell lysates were clarified by centrifugation. Equivalent amount of
cell lysate protein was incubated with 25 or 50 mL streptavidin
agarose resin (Thermo Scientific 20349) for ,2 h or overnight.
Beads were washed three times with 1 mL EBC buffer. Proteins
were eluted with SDS and analyzed by immunoblotting with anti-
Nlrp1b or anti-CBP antibody. CBP is an epitope found within the
TAP tag.
Co-immunoprecipitation assays
To test self-association of Nlrp1b1 truncation mutants, two
plates of HT1080 cells were transfected with pcDNA3-His6-
Nlrp1b1-HA and pcDNA3-His6-Nlrp1b1-T7 vectors containing
trunction mutants. Approximately 24 h following transfection,
cells were lysed in 300 mL EBC buffer by sonication, and lysates
were clarified by centrifugation. Equal amount of lysate protein
was incubated overnight with 1 mL of anti-HA antibody (Sigma-
Aldrich H9658), followed by the addition of 50 mL of BSA-blocked
protein A Sepharose beads (GE Healthcare) and a 2 h incubation
at 4uC. Complexes were resolved by SDS-polyacrylamide gel
electrophoresis and immunoblotted using an anti-T7 antibody.
A similar protocol as above was followed to test for Nlrp1b1720–
1233 self-association and pro-caspase-1 binding, with the exception
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4 mg. Lysates were incubated with 1 ml of anti-T7 antibody or
1 mL of control anti-GFP antibody overnight. Membranes were
immunoblotted with anti-caspase-1 p10, anti-HA, anti-T7, and
anti-b-actin antibodies.
A similar protocol as above was followed to test for the
association of the Nlrp1b1 cleaved products with the exception
that the vectors indicated in Figure 7 were transfected to a total of
4 mg. Lysates were incubated overnight with 50 mL streptavidin
agarose resin slurry, followed by washing three times with 1 mL
EBC buffer. Proteins were eluted from the beads with SDS and
analyzed by immunoblotting with anti-HA and anti-b-actin
antibodies.
For the experiment shown in Figure 3C, two 10-cm dishes of
HT1080 cells were transfected with pcDNA3-pro-caspase-1-T7-
C284A and either pcDNA3-His6-Nlrp1b11100–1233-HA, pcDNA3-
His6-Nlrp1b11100–1233-7A-HA or pcDNA3-His6-Nlrp1b11100–1233-
HA. Cells were lysed in 600 mL EBC buffer by sonication, and the
lysates were clarified by centrifugation. Lysates were incubated
with 1 mL of anti-T7 antibody or 1 mL of control anti-GFP
antibody overnight, followed by the addition of 50 mL of protein A
Sepharose for 2 h. Complexes were resolved by SDS-polyacryl-
amide gel electrophoresis and immunoblotted using an anti-HA
antibody and anti-caspase-1 p10 antibody.
Supporting Information
Figure S1 The S984A mutation in Nlrp1b1 eliminates
both cleavage and inflammasome activity. (A) HT1080
cells were transfected with pNTAP plasmids encoding the
indicated Nlrp1b proteins. Approximately 24 h following trans-
fection, cells were lysed and TAP-tagged proteins were precip-
itated with streptavidin resin and immunoblotted using an Nlrp1b
antibody. (B) Cells were transfected with pNTAP plasmids
encoding the indicated Nlrp1b constructs, as well as with
pcDNA3-pro-caspase-1-T7 and pcDNA3-pro-IL-1b-HA. Approx-
imately 24 h after transfection, cells were treated with LeTx
(10
28 M LF and 10
28 M PA) for 3 h. Cell lysates were collected
and probed for HA-tagged pro-IL-1b and b-actin; cell superna-
tants were collected and immunoprecipitated with anti-HA
antibodies and probed for HA-tagged IL-1b by immunoblotting.
Blots are representative of three independent experiments.
(TIF)
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